Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ali Asif | Chief Financial Officer | Sep 11 '24 | Option Exercise | 15.68 | 12,000 | 188,160 | 46,960 | Sep 13 04:35 PM | Ali Asif | Chief Financial Officer | Sep 11 '24 | Sale | 44.49 | 14,203 | 631,872 | 34,960 | Sep 13 04:35 PM | Waddill William D. | Director | Sep 10 '24 | Option Exercise | 12.88 | 8,000 | 103,040 | 20,000 | Sep 12 07:38 PM | Waddill William D. | Director | Sep 10 '24 | Sale | 45.00 | 8,000 | 360,000 | 12,000 | Sep 12 07:38 PM | Ali Asif | Officer | Sep 11 '24 | Proposed Sale | 44.49 | 14,203 | 631,855 | | Sep 11 06:15 PM | WILLIAM D WADDILL | Director | Sep 10 '24 | Proposed Sale | 45.00 | 8,000 | 360,000 | | Sep 10 04:17 PM | Waddill William D. | Director | Jul 24 '24 | Option Exercise | 12.88 | 8,000 | 103,040 | 20,000 | Jul 26 04:31 PM | Waddill William D. | Director | Jul 24 '24 | Sale | 40.00 | 8,000 | 320,000 | 12,000 | Jul 26 04:31 PM | Waddill William D. | Director | Jun 07 '24 | Option Exercise | 12.88 | 8,000 | 103,040 | 20,000 | Jun 11 04:30 PM | Waddill William D. | Director | Jun 07 '24 | Sale | 35.00 | 8,000 | 280,000 | 12,000 | Jun 11 04:30 PM | PATEL DINESH V PH D | President and CEO | Jun 07 '24 | Sale | 35.19 | 35,000 | 1,231,650 | 515,415 | Jun 11 04:30 PM | Ali Asif | Chief Financial Officer | Apr 18 '24 | Sale | 25.11 | 1,234 | 30,986 | 37,163 | Apr 19 08:05 PM | PATEL DINESH V PH D | President and CEO | Apr 01 '24 | Sale | 28.31 | 25,000 | 707,750 | 549,590 | Apr 02 08:29 PM | SELICK HAROLD E | Director | Mar 07 '24 | Option Exercise | 1.89 | 6,490 | 12,266 | 27,996 | Mar 11 08:00 PM | PATEL DINESH V PH D | President and CEO | Mar 01 '24 | Sale | 31.62 | 30,000 | 948,600 | 574,590 | Mar 01 08:46 PM | Waddill William D. | Director | Mar 01 '24 | Option Exercise | 6.09 | 12,975 | 79,018 | 24,975 | Mar 01 08:45 PM | Waddill William D. | Director | Mar 01 '24 | Sale | 31.34 | 12,975 | 406,636 | 12,000 | Mar 01 08:45 PM | Ali Asif | Chief Financial Officer | Mar 01 '24 | Option Exercise | 12.17 | 12,000 | 146,040 | 52,645 | Mar 01 08:45 PM | Ali Asif | Chief Financial Officer | Mar 01 '24 | Sale | 32.24 | 14,248 | 459,318 | 38,397 | Mar 01 08:45 PM | Ali Asif | Chief Financial Officer | Feb 29 '24 | Sale | 30.69 | 9,939 | 305,048 | 40,645 | Mar 01 08:45 PM | Gupta Suneel | Chief Development Officer | Jan 09 '24 | Option Exercise | 7.38 | 5,000 | 36,900 | 192,567 | Jan 11 08:00 PM | Gupta Suneel | Chief Development Officer | Jan 09 '24 | Sale | 25.00 | 5,000 | 125,000 | 187,567 | Jan 11 08:00 PM | MOLINA ARTURO MD | Chief Medical Officer | Nov 15 '23 | Sale | 16.24 | 1,848 | 30,012 | 22,527 | Jan 04 08:09 PM | PATEL DINESH V PH D | President and CEO | Dec 13 '23 | Sale | 20.08 | 75,000 | 1,506,000 | 534,347 | Dec 15 04:30 PM |
|